nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—PTGS2—colon cancer	0.692	1	CbGaD
Tolmetin—MPO—superior mesenteric artery—colon cancer	0.0643	0.46	CbGeAlD
Tolmetin—Optic nerve disorder—Fluorouracil—colon cancer	0.0117	0.136	CcSEcCtD
Tolmetin—MPO—endothelium—colon cancer	0.00581	0.0415	CbGeAlD
Tolmetin—MPO—blood vessel—colon cancer	0.00536	0.0383	CbGeAlD
Tolmetin—TDO2—liver—colon cancer	0.00459	0.0328	CbGeAlD
Tolmetin—CXCL8—smooth muscle tissue—colon cancer	0.0043	0.0307	CbGeAlD
Tolmetin—Skin irritation—Fluorouracil—colon cancer	0.00365	0.0427	CcSEcCtD
Tolmetin—TDO2—lymph node—colon cancer	0.00352	0.0251	CbGeAlD
Tolmetin—CXCL8—bone marrow—colon cancer	0.00313	0.0223	CbGeAlD
Tolmetin—CXCL8—vagina—colon cancer	0.003	0.0214	CbGeAlD
Tolmetin—PTGS1—endothelium—colon cancer	0.00276	0.0197	CbGeAlD
Tolmetin—PTGS2—endothelium—colon cancer	0.00263	0.0188	CbGeAlD
Tolmetin—MPO—epithelium—colon cancer	0.00261	0.0186	CbGeAlD
Tolmetin—PTGS1—blood vessel—colon cancer	0.00254	0.0182	CbGeAlD
Tolmetin—CXCL8—liver—colon cancer	0.00253	0.0181	CbGeAlD
Tolmetin—PTGS2—blood vessel—colon cancer	0.00243	0.0174	CbGeAlD
Tolmetin—MPO—renal system—colon cancer	0.00242	0.0173	CbGeAlD
Tolmetin—PTGS2—gall bladder—colon cancer	0.00229	0.0163	CbGeAlD
Tolmetin—MPO—lymphoid tissue—colon cancer	0.00201	0.0143	CbGeAlD
Tolmetin—MPO—digestive system—colon cancer	0.00198	0.0142	CbGeAlD
Tolmetin—CXCL8—lymph node—colon cancer	0.00194	0.0138	CbGeAlD
Tolmetin—MPO—bone marrow—colon cancer	0.00183	0.0131	CbGeAlD
Tolmetin—MPO—liver—colon cancer	0.00148	0.0106	CbGeAlD
Tolmetin—PTGS2—embryo—colon cancer	0.00145	0.0104	CbGeAlD
Tolmetin—Ketorolac—PTGS2—colon cancer	0.00131	0.162	CrCbGaD
Tolmetin—Visual disturbance—Irinotecan—colon cancer	0.00126	0.0148	CcSEcCtD
Tolmetin—Proteinuria—Capecitabine—colon cancer	0.00125	0.0147	CcSEcCtD
Tolmetin—Bromfenac—PTGS2—colon cancer	0.00125	0.156	CrCbGaD
Tolmetin—Protein urine present—Capecitabine—colon cancer	0.00124	0.0145	CcSEcCtD
Tolmetin—PTGS1—epithelium—colon cancer	0.00124	0.00884	CbGeAlD
Tolmetin—Anaphylactoid reaction—Irinotecan—colon cancer	0.00124	0.0145	CcSEcCtD
Tolmetin—Indomethacin—PPARG—colon cancer	0.00122	0.151	CrCbGaD
Tolmetin—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.0012	0.014	CcSEcCtD
Tolmetin—PTGS1—smooth muscle tissue—colon cancer	0.00119	0.00852	CbGeAlD
Tolmetin—PTGS2—epithelium—colon cancer	0.00118	0.00845	CbGeAlD
Tolmetin—PTGS1—renal system—colon cancer	0.00115	0.0082	CbGeAlD
Tolmetin—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00115	0.0134	CcSEcCtD
Tolmetin—PTGS2—smooth muscle tissue—colon cancer	0.00114	0.00814	CbGeAlD
Tolmetin—MPO—lymph node—colon cancer	0.00113	0.0081	CbGeAlD
Tolmetin—PTGS1—Overview of nanoparticle effects—BAX—colon cancer	0.00111	0.015	CbGpPWpGaD
Tolmetin—Blood pressure increased—Capecitabine—colon cancer	0.0011	0.0129	CcSEcCtD
Tolmetin—PTGS2—renal system—colon cancer	0.0011	0.00784	CbGeAlD
Tolmetin—Lumiracoxib—PTGS2—colon cancer	0.00106	0.132	CrCbGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—FGFR3—colon cancer	0.00101	0.0135	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CA7—colon cancer	0.001	0.0135	CbGpPWpGaD
Tolmetin—Dysuria—Vincristine—colon cancer	0.000992	0.0116	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—BRAF—colon cancer	0.000978	0.0131	CbGpPWpGaD
Tolmetin—Fenbufen—PTGS2—colon cancer	0.000969	0.12	CrCbGaD
Tolmetin—Weight decreased—Vincristine—colon cancer	0.00096	0.0112	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—CDH1—colon cancer	0.000958	0.0129	CbGpPWpGaD
Tolmetin—PTGS1—digestive system—colon cancer	0.000941	0.00672	CbGeAlD
Tolmetin—Weight decreased—Irinotecan—colon cancer	0.000935	0.0109	CcSEcCtD
Tolmetin—Proteinuria—Methotrexate—colon cancer	0.000934	0.0109	CcSEcCtD
Tolmetin—Stomatitis—Vincristine—colon cancer	0.000922	0.0108	CcSEcCtD
Tolmetin—Protein urine present—Methotrexate—colon cancer	0.000921	0.0108	CcSEcCtD
Tolmetin—PTGS2—lymphoid tissue—colon cancer	0.000911	0.00651	CbGeAlD
Tolmetin—Renal failure—Irinotecan—colon cancer	0.000906	0.0106	CcSEcCtD
Tolmetin—PTGS2—digestive system—colon cancer	0.0009	0.00643	CbGeAlD
Tolmetin—Stomatitis—Irinotecan—colon cancer	0.000898	0.0105	CcSEcCtD
Tolmetin—Vascular purpura—Capecitabine—colon cancer	0.000895	0.0105	CcSEcCtD
Tolmetin—Glossitis—Methotrexate—colon cancer	0.000891	0.0104	CcSEcCtD
Tolmetin—Haemolytic anaemia—Capecitabine—colon cancer	0.000887	0.0104	CcSEcCtD
Tolmetin—PTGS2—Overview of nanoparticle effects—BAX—colon cancer	0.000885	0.0119	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-3-mediated signaling events—SRC—colon cancer	0.000872	0.0117	CbGpPWpGaD
Tolmetin—Stomatitis—Fluorouracil—colon cancer	0.00086	0.0101	CcSEcCtD
Tolmetin—Urinary tract infection—Fluorouracil—colon cancer	0.000858	0.01	CcSEcCtD
Tolmetin—Epistaxis—Fluorouracil—colon cancer	0.000833	0.00974	CcSEcCtD
Tolmetin—PTGS1—vagina—colon cancer	0.000831	0.00594	CbGeAlD
Tolmetin—Purpura—Capecitabine—colon cancer	0.00083	0.00971	CcSEcCtD
Tolmetin—PTGS2—bone marrow—colon cancer	0.000829	0.00592	CbGeAlD
Tolmetin—Agranulocytosis—Fluorouracil—colon cancer	0.000824	0.00964	CcSEcCtD
Tolmetin—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—colon cancer	0.000823	0.011	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—BCL2L1—colon cancer	0.000822	0.011	CbGpPWpGaD
Tolmetin—Suprofen—PTGS2—colon cancer	0.000807	0.1	CrCbGaD
Tolmetin—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.0008	0.00936	CcSEcCtD
Tolmetin—Visual impairment—Irinotecan—colon cancer	0.000797	0.00933	CcSEcCtD
Tolmetin—PTGS2—vagina—colon cancer	0.000794	0.00568	CbGeAlD
Tolmetin—CXCL8—Syndecan-3-mediated signaling events—EGFR—colon cancer	0.000765	0.0103	CbGpPWpGaD
Tolmetin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000721	0.00843	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—CCND1—colon cancer	0.000714	0.00958	CbGpPWpGaD
Tolmetin—Flatulence—Irinotecan—colon cancer	0.00071	0.0083	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—BCL2L1—colon cancer	0.000708	0.00951	CbGpPWpGaD
Tolmetin—Gastritis—Capecitabine—colon cancer	0.000708	0.00829	CcSEcCtD
Tolmetin—Lymphadenopathy—Methotrexate—colon cancer	0.000698	0.00817	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—CDKN1A—colon cancer	0.00069	0.00927	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—colon cancer	0.000685	0.00919	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—ABCB1—colon cancer	0.000683	0.00917	CbGpPWpGaD
Tolmetin—PTGS2—liver—colon cancer	0.00067	0.00479	CbGeAlD
Tolmetin—Abdominal discomfort—Capecitabine—colon cancer	0.000663	0.00776	CcSEcCtD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—CASP3—colon cancer	0.000651	0.00873	CbGpPWpGaD
Tolmetin—Dysuria—Capecitabine—colon cancer	0.000647	0.00757	CcSEcCtD
Tolmetin—PTGS1—Overview of nanoparticle effects—PTGS2—colon cancer	0.000645	0.00865	CbGpPWpGaD
Tolmetin—Weight increased—Capecitabine—colon cancer	0.00063	0.00736	CcSEcCtD
Tolmetin—Visual disturbance—Methotrexate—colon cancer	0.000629	0.00735	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—BAX—colon cancer	0.000627	0.00842	CbGpPWpGaD
Tolmetin—Weight decreased—Capecitabine—colon cancer	0.000626	0.00732	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—VEGFA—colon cancer	0.000622	0.00835	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—colon cancer	0.00062	0.00831	CbGpPWpGaD
Tolmetin—Anaphylactoid reaction—Methotrexate—colon cancer	0.000616	0.0072	CcSEcCtD
Tolmetin—TDO2—Metabolism—CHST5—colon cancer	0.000609	0.00817	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ODC1—colon cancer	0.000609	0.00817	CbGpPWpGaD
Tolmetin—Renal failure—Capecitabine—colon cancer	0.000606	0.00709	CcSEcCtD
Tolmetin—Oedema—Vincristine—colon cancer	0.000604	0.00706	CcSEcCtD
Tolmetin—Anaphylactic shock—Vincristine—colon cancer	0.000604	0.00706	CcSEcCtD
Tolmetin—Stomatitis—Capecitabine—colon cancer	0.000601	0.00703	CcSEcCtD
Tolmetin—Urinary tract infection—Capecitabine—colon cancer	0.0006	0.00701	CcSEcCtD
Tolmetin—Thrombocytopenia—Vincristine—colon cancer	0.000591	0.00691	CcSEcCtD
Tolmetin—Haematuria—Capecitabine—colon cancer	0.000588	0.00688	CcSEcCtD
Tolmetin—Anaphylactic shock—Irinotecan—colon cancer	0.000588	0.00688	CcSEcCtD
Tolmetin—Oedema—Irinotecan—colon cancer	0.000588	0.00688	CcSEcCtD
Tolmetin—Chest pain—Fluorouracil—colon cancer	0.000587	0.00687	CcSEcCtD
Tolmetin—Epistaxis—Capecitabine—colon cancer	0.000582	0.00681	CcSEcCtD
Tolmetin—Agranulocytosis—Capecitabine—colon cancer	0.000576	0.00673	CcSEcCtD
Tolmetin—Thrombocytopenia—Irinotecan—colon cancer	0.000575	0.00673	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—MYC—colon cancer	0.000573	0.00768	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—colon cancer	0.00057	0.00765	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—PIK3CA—colon cancer	0.000569	0.00763	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—SRC—colon cancer	0.000567	0.00761	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Fluorouracil—colon cancer	0.000563	0.00658	CcSEcCtD
Tolmetin—Oedema—Fluorouracil—colon cancer	0.000563	0.00658	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—EGFR—colon cancer	0.00056	0.00752	CbGpPWpGaD
Tolmetin—Hepatitis—Capecitabine—colon cancer	0.000554	0.00648	CcSEcCtD
Tolmetin—Thrombocytopenia—Fluorouracil—colon cancer	0.000551	0.00645	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—colon cancer	0.000539	0.00723	CbGpPWpGaD
Tolmetin—PTGS1—lymph node—colon cancer	0.000538	0.00384	CbGeAlD
Tolmetin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000537	0.00628	CcSEcCtD
Tolmetin—PTGS1—Eicosanoid Synthesis—PTGS2—colon cancer	0.000535	0.00718	CbGpPWpGaD
Tolmetin—Visual impairment—Capecitabine—colon cancer	0.000534	0.00624	CcSEcCtD
Tolmetin—Erythema multiforme—Capecitabine—colon cancer	0.000524	0.00612	CcSEcCtD
Tolmetin—Somnolence—Irinotecan—colon cancer	0.000523	0.00611	CcSEcCtD
Tolmetin—Dyspepsia—Irinotecan—colon cancer	0.000517	0.00605	CcSEcCtD
Tolmetin—Tinnitus—Capecitabine—colon cancer	0.000516	0.00604	CcSEcCtD
Tolmetin—Constipation—Vincristine—colon cancer	0.000516	0.00604	CcSEcCtD
Tolmetin—PTGS2—lymph node—colon cancer	0.000514	0.00367	CbGeAlD
Tolmetin—Indomethacin—PTGS2—colon cancer	0.000513	0.0638	CrCbGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—TGFB1—colon cancer	0.000507	0.0068	CbGpPWpGaD
Tolmetin—Constipation—Irinotecan—colon cancer	0.000503	0.00588	CcSEcCtD
Tolmetin—Somnolence—Fluorouracil—colon cancer	0.0005	0.00585	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	0.0005	0.00671	CbGpPWpGaD
Tolmetin—Dyspepsia—Fluorouracil—colon cancer	0.000496	0.0058	CcSEcCtD
Tolmetin—Abdominal discomfort—Methotrexate—colon cancer	0.000494	0.00577	CcSEcCtD
Tolmetin—Gastrointestinal pain—Vincristine—colon cancer	0.000494	0.00577	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—APC—colon cancer	0.000487	0.00654	CbGpPWpGaD
Tolmetin—Dysuria—Methotrexate—colon cancer	0.000482	0.00563	CcSEcCtD
Tolmetin—Gastrointestinal pain—Irinotecan—colon cancer	0.000481	0.00562	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—PTGS2—colon cancer	0.00048	0.00644	CbGpPWpGaD
Tolmetin—Abdominal pain—Vincristine—colon cancer	0.000477	0.00558	CcSEcCtD
Tolmetin—Body temperature increased—Vincristine—colon cancer	0.000477	0.00558	CcSEcCtD
Tolmetin—Aminohippurate—ABCB1—colon cancer	0.000476	0.0592	CrCbGaD
Tolmetin—Flatulence—Capecitabine—colon cancer	0.000475	0.00556	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—TP53—colon cancer	0.00047	0.00631	CbGpPWpGaD
Tolmetin—Body temperature increased—Irinotecan—colon cancer	0.000465	0.00544	CcSEcCtD
Tolmetin—Abdominal pain—Irinotecan—colon cancer	0.000465	0.00544	CcSEcCtD
Tolmetin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—colon cancer	0.000463	0.00621	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—PTGS2—colon cancer	0.000462	0.0062	CbGpPWpGaD
Tolmetin—Drowsiness—Methotrexate—colon cancer	0.000459	0.00537	CcSEcCtD
Tolmetin—CXCL8—TSLP Signaling Pathway—SRC—colon cancer	0.000458	0.00615	CbGpPWpGaD
Tolmetin—Renal failure—Methotrexate—colon cancer	0.000451	0.00528	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—HRAS—colon cancer	0.00045	0.00603	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—colon cancer	0.000449	0.00602	CbGpPWpGaD
Tolmetin—Stomatitis—Methotrexate—colon cancer	0.000448	0.00524	CcSEcCtD
Tolmetin—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	0.000447	0.00601	CbGpPWpGaD
Tolmetin—Urticaria—Fluorouracil—colon cancer	0.000447	0.00523	CcSEcCtD
Tolmetin—Body temperature increased—Fluorouracil—colon cancer	0.000445	0.00521	CcSEcCtD
Tolmetin—CXCL8—IL-3 Signaling Pathway—SRC—colon cancer	0.000443	0.00594	CbGpPWpGaD
Tolmetin—Haematuria—Methotrexate—colon cancer	0.000438	0.00512	CcSEcCtD
Tolmetin—Indomethacin—ABCB1—colon cancer	0.000436	0.0543	CrCbGaD
Tolmetin—MPO—C-MYB transcription factor network—CCND1—colon cancer	0.000434	0.00582	CbGpPWpGaD
Tolmetin—Epistaxis—Methotrexate—colon cancer	0.000433	0.00507	CcSEcCtD
Tolmetin—Asthenia—Vincristine—colon cancer	0.000433	0.00507	CcSEcCtD
Tolmetin—CXCL8—IL8- and CXCR1-mediated signaling events—AKT1—colon cancer	0.000431	0.00578	CbGpPWpGaD
Tolmetin—Agranulocytosis—Methotrexate—colon cancer	0.000428	0.00501	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—CCND1—colon cancer	0.000427	0.00572	CbGpPWpGaD
Tolmetin—Asthenia—Irinotecan—colon cancer	0.000422	0.00493	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—CDKN1A—colon cancer	0.000419	0.00563	CbGpPWpGaD
Tolmetin—Diarrhoea—Vincristine—colon cancer	0.000413	0.00483	CcSEcCtD
Tolmetin—Hepatitis—Methotrexate—colon cancer	0.000412	0.00482	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000412	0.00553	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—CASP3—colon cancer	0.000411	0.00551	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—MYC—colon cancer	0.00041	0.00551	CbGpPWpGaD
Tolmetin—Chest pain—Capecitabine—colon cancer	0.00041	0.0048	CcSEcCtD
Tolmetin—CXCL8—Corticotropin-releasing hormone—BRAF—colon cancer	0.00041	0.0055	CbGpPWpGaD
Tolmetin—PTGS2—S1P1 pathway—VEGFA—colon cancer	0.000403	0.00541	CbGpPWpGaD
Tolmetin—Diarrhoea—Irinotecan—colon cancer	0.000402	0.0047	CcSEcCtD
Tolmetin—Dizziness—Vincristine—colon cancer	0.000399	0.00467	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—EP300—colon cancer	0.000399	0.00536	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—HRAS—colon cancer	0.000399	0.00535	CbGpPWpGaD
Tolmetin—Visual impairment—Methotrexate—colon cancer	0.000397	0.00465	CcSEcCtD
Tolmetin—CXCL8—IL-3 Signaling Pathway—TGFB1—colon cancer	0.000396	0.00531	CbGpPWpGaD
Tolmetin—Oedema—Capecitabine—colon cancer	0.000393	0.0046	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—EP300—colon cancer	0.000393	0.00527	CbGpPWpGaD
Tolmetin—Erythema multiforme—Methotrexate—colon cancer	0.00039	0.00456	CcSEcCtD
Tolmetin—Dizziness—Irinotecan—colon cancer	0.000389	0.00455	CcSEcCtD
Tolmetin—Diarrhoea—Fluorouracil—colon cancer	0.000385	0.00451	CcSEcCtD
Tolmetin—Thrombocytopenia—Capecitabine—colon cancer	0.000385	0.00451	CcSEcCtD
Tolmetin—Tinnitus—Methotrexate—colon cancer	0.000384	0.0045	CcSEcCtD
Tolmetin—Vomiting—Vincristine—colon cancer	0.000384	0.00449	CcSEcCtD
Tolmetin—Headache—Vincristine—colon cancer	0.000378	0.00442	CcSEcCtD
Tolmetin—Vomiting—Irinotecan—colon cancer	0.000374	0.00437	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—NRAS—colon cancer	0.000373	0.00501	CbGpPWpGaD
Tolmetin—Dizziness—Fluorouracil—colon cancer	0.000372	0.00435	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—CCND1—colon cancer	0.000372	0.00499	CbGpPWpGaD
Tolmetin—CXCL8—IL8- and CXCR2-mediated signaling events—AKT1—colon cancer	0.000369	0.00495	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—BRAF—colon cancer	0.000369	0.00495	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CTNNB1—colon cancer	0.000368	0.00494	CbGpPWpGaD
Tolmetin—Headache—Irinotecan—colon cancer	0.000368	0.00431	CcSEcCtD
Tolmetin—Nausea—Vincristine—colon cancer	0.000358	0.00419	CcSEcCtD
Tolmetin—Vomiting—Fluorouracil—colon cancer	0.000358	0.00419	CcSEcCtD
Tolmetin—CXCL8—LPA receptor mediated events—SRC—colon cancer	0.000358	0.0048	CbGpPWpGaD
Tolmetin—Headache—Fluorouracil—colon cancer	0.000353	0.00413	CcSEcCtD
Tolmetin—Nausea—Irinotecan—colon cancer	0.000349	0.00408	CcSEcCtD
Tolmetin—CXCL8—TSLP Signaling Pathway—PIK3CA—colon cancer	0.000348	0.00468	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—MYC—colon cancer	0.000348	0.00467	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—CASP3—colon cancer	0.000347	0.00466	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TP53—colon cancer	0.000346	0.00465	CbGpPWpGaD
Tolmetin—Dyspepsia—Capecitabine—colon cancer	0.000346	0.00405	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—EP300—colon cancer	0.000342	0.0046	CbGpPWpGaD
Tolmetin—Constipation—Capecitabine—colon cancer	0.000336	0.00393	CcSEcCtD
Tolmetin—Nausea—Fluorouracil—colon cancer	0.000334	0.00391	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—colon cancer	0.000334	0.00449	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—colon cancer	0.000331	0.00444	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Capecitabine—colon cancer	0.000322	0.00376	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—KRAS—colon cancer	0.000321	0.00431	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	0.000317	0.00426	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—EGFR—colon cancer	0.000314	0.00421	CbGpPWpGaD
Tolmetin—Urticaria—Capecitabine—colon cancer	0.000313	0.00366	CcSEcCtD
Tolmetin—CXCL8—IL-3 Signaling Pathway—HRAS—colon cancer	0.000312	0.00418	CbGpPWpGaD
Tolmetin—Abdominal pain—Capecitabine—colon cancer	0.000311	0.00364	CcSEcCtD
Tolmetin—Body temperature increased—Capecitabine—colon cancer	0.000311	0.00364	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—colon cancer	0.000308	0.00413	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—CASP3—colon cancer	0.000307	0.00412	CbGpPWpGaD
Tolmetin—Chest pain—Methotrexate—colon cancer	0.000305	0.00357	CcSEcCtD
Tolmetin—CXCL8—Metabolism of proteins—CDX2—colon cancer	0.000302	0.00406	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—EP300—colon cancer	0.000302	0.00405	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—colon cancer	0.0003	0.00403	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—MYC—colon cancer	0.000298	0.004	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TGFB1—colon cancer	0.000298	0.00399	CbGpPWpGaD
Tolmetin—PTGS1—Arachidonic acid metabolism—PTGS2—colon cancer	0.000297	0.00399	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—CTNNB1—colon cancer	0.000296	0.00397	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—VEGFA—colon cancer	0.000294	0.00395	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Methotrexate—colon cancer	0.000293	0.00343	CcSEcCtD
Tolmetin—Thrombocytopenia—Methotrexate—colon cancer	0.000287	0.00335	CcSEcCtD
Tolmetin—CXCL8—TSLP Signaling Pathway—AKT1—colon cancer	0.000285	0.00382	CbGpPWpGaD
Tolmetin—Asthenia—Capecitabine—colon cancer	0.000282	0.0033	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000281	0.00377	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—AKT1—colon cancer	0.000275	0.00369	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—HRAS—colon cancer	0.000273	0.00367	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—PTGS2—colon cancer	0.000271	0.00364	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TGFB1—colon cancer	0.00027	0.00363	CbGpPWpGaD
Tolmetin—Diarrhoea—Capecitabine—colon cancer	0.000269	0.00315	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—colon cancer	0.000268	0.0036	CbGpPWpGaD
Tolmetin—Somnolence—Methotrexate—colon cancer	0.00026	0.00305	CcSEcCtD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN1A—colon cancer	0.00026	0.00349	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CDKN1A—colon cancer	0.00026	0.00349	CbGpPWpGaD
Tolmetin—Dizziness—Capecitabine—colon cancer	0.00026	0.00304	CcSEcCtD
Tolmetin—Dyspepsia—Methotrexate—colon cancer	0.000258	0.00302	CcSEcCtD
Tolmetin—CXCL8—Metabolism of proteins—MUC2—colon cancer	0.000257	0.00345	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—HRAS—colon cancer	0.000252	0.00338	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CASP3—colon cancer	0.000252	0.00338	CbGpPWpGaD
Tolmetin—Vomiting—Capecitabine—colon cancer	0.00025	0.00293	CcSEcCtD
Tolmetin—Headache—Capecitabine—colon cancer	0.000246	0.00288	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—TP53—colon cancer	0.000245	0.00329	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CCND1—colon cancer	0.000245	0.00329	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—SRC—colon cancer	0.000241	0.00323	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Methotrexate—colon cancer	0.000239	0.0028	CcSEcCtD
Tolmetin—CXCL8—Corticotropin-releasing hormone—TGFB1—colon cancer	0.000239	0.00321	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000237	0.00317	CbGpPWpGaD
Tolmetin—Nausea—Capecitabine—colon cancer	0.000234	0.00273	CcSEcCtD
Tolmetin—Urticaria—Methotrexate—colon cancer	0.000233	0.00272	CcSEcCtD
Tolmetin—Body temperature increased—Methotrexate—colon cancer	0.000232	0.00271	CcSEcCtD
Tolmetin—Abdominal pain—Methotrexate—colon cancer	0.000232	0.00271	CcSEcCtD
Tolmetin—CXCL8—LPA receptor mediated events—AKT1—colon cancer	0.000222	0.00298	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.000221	0.00296	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	0.000219	0.00294	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CA7—colon cancer	0.000216	0.0029	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—TP53—colon cancer	0.000216	0.0029	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TGFB1—colon cancer	0.000215	0.00289	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—DLC1—colon cancer	0.000211	0.00283	CbGpPWpGaD
Tolmetin—Asthenia—Methotrexate—colon cancer	0.00021	0.00246	CcSEcCtD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.00021	0.00282	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.000204	0.00274	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000201	0.0027	CbGpPWpGaD
Tolmetin—Diarrhoea—Methotrexate—colon cancer	0.0002	0.00234	CcSEcCtD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000199	0.00267	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LGR5—colon cancer	0.000198	0.00266	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—MYC—colon cancer	0.000197	0.00264	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.000196	0.00264	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TGFB1—colon cancer	0.000196	0.00263	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000194	0.0026	CbGpPWpGaD
Tolmetin—Dizziness—Methotrexate—colon cancer	0.000194	0.00227	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—EGFR—colon cancer	0.000192	0.00258	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—PTGS2—colon cancer	0.000189	0.00254	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000189	0.00254	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—PIK3CA—colon cancer	0.000187	0.00252	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	0.000187	0.00251	CbGpPWpGaD
Tolmetin—Vomiting—Methotrexate—colon cancer	0.000186	0.00218	CcSEcCtD
Tolmetin—Headache—Methotrexate—colon cancer	0.000183	0.00215	CcSEcCtD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000183	0.00245	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—AKT1—colon cancer	0.000182	0.00245	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—EP300—colon cancer	0.00018	0.00242	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000179	0.0024	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—colon cancer	0.000177	0.00238	CbGpPWpGaD
Tolmetin—Nausea—Methotrexate—colon cancer	0.000174	0.00203	CcSEcCtD
Tolmetin—PTGS2—Metabolism—CA7—colon cancer	0.000171	0.0023	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000171	0.00229	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—HRAS—colon cancer	0.000169	0.00227	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000169	0.00227	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—AKT1—colon cancer	0.000166	0.00223	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN1A—colon cancer	0.000165	0.00221	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—colon cancer	0.000161	0.00217	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ABCB1—colon cancer	0.000161	0.00216	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—TYMS—colon cancer	0.000158	0.00212	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—AKT1—colon cancer	0.000153	0.00205	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000148	0.00198	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—PIK3CA—colon cancer	0.000146	0.00196	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000145	0.00195	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.000144	0.00193	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AXIN2—colon cancer	0.000142	0.00191	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CCND1—colon cancer	0.000141	0.00189	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.00014	0.00187	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN1A—colon cancer	0.000136	0.00183	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ODC1—colon cancer	0.000131	0.00176	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CHST5—colon cancer	0.000131	0.00176	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—EP300—colon cancer	0.00013	0.00174	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1A—colon cancer	0.000124	0.00167	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CHST5—colon cancer	0.000124	0.00166	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LGR5—colon cancer	0.000124	0.00166	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—NRAS—colon cancer	0.000121	0.00163	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—AKT1—colon cancer	0.00012	0.0016	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—EP300—colon cancer	0.000118	0.00159	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—MYC—colon cancer	0.000113	0.00152	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—colon cancer	0.000112	0.00151	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—colon cancer	0.000112	0.0015	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PPARG—colon cancer	0.000112	0.0015	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CASP3—colon cancer	0.00011	0.00148	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCND1—colon cancer	0.000107	0.00144	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000106	0.00143	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—KRAS—colon cancer	0.000104	0.0014	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CHST5—colon cancer	0.000104	0.00139	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ODC1—colon cancer	0.000104	0.00139	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	9.12e-05	0.00122	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AXIN2—colon cancer	8.91e-05	0.0012	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—HRAS—colon cancer	8.87e-05	0.00119	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—colon cancer	8.8e-05	0.00118	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—colon cancer	8.61e-05	0.00116	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TGFB1—colon cancer	8.59e-05	0.00115	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—colon cancer	8.47e-05	0.00114	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—colon cancer	8.42e-05	0.00113	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	7.5e-05	0.00101	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—EP300—colon cancer	7.32e-05	0.000983	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	7.3e-05	0.00098	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	7.23e-05	0.00097	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—colon cancer	7.07e-05	0.000949	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	7.06e-05	0.000948	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.72e-05	0.000902	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	6.53e-05	0.000877	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	6.36e-05	0.000854	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CTNNB1—colon cancer	5.95e-05	0.000799	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.86e-05	0.000786	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.84e-05	0.000784	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.73e-05	0.000769	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—colon cancer	5.42e-05	0.000727	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.41e-05	0.000726	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.4e-05	0.000725	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.97e-05	0.000667	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.81e-05	0.000645	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKT1—colon cancer	4.43e-05	0.000594	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.29e-05	0.000576	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.25e-05	0.00057	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGFR3—colon cancer	4.11e-05	0.000552	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	4.06e-05	0.000545	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—APC—colon cancer	3.78e-05	0.000507	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—NRAS—colon cancer	3.78e-05	0.000507	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BRAF—colon cancer	3.55e-05	0.000477	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.53e-05	0.000474	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ABCB1—colon cancer	3.46e-05	0.000464	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—colon cancer	3.44e-05	0.000462	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TYMS—colon cancer	3.4e-05	0.000456	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—colon cancer	3.29e-05	0.000441	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KRAS—colon cancer	3.25e-05	0.000436	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—colon cancer	2.99e-05	0.000401	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.81e-05	0.000377	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRAS—colon cancer	2.76e-05	0.000371	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCB1—colon cancer	2.75e-05	0.000368	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TYMS—colon cancer	2.7e-05	0.000362	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT1—colon cancer	2.69e-05	0.000361	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CASP3—colon cancer	2.66e-05	0.000357	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.61e-05	0.000351	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—colon cancer	2.59e-05	0.000348	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGFR3—colon cancer	2.57e-05	0.000345	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CTNNB1—colon cancer	2.57e-05	0.000344	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1A—colon cancer	2.51e-05	0.000336	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT1—colon cancer	2.44e-05	0.000327	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PPARG—colon cancer	2.41e-05	0.000323	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EP300—colon cancer	2.39e-05	0.00032	CbGpPWpGaD
Tolmetin—PTGS2—Disease—APC—colon cancer	2.36e-05	0.000317	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SRC—colon cancer	2.32e-05	0.000311	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—colon cancer	2.26e-05	0.000303	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NRAS—colon cancer	2.23e-05	0.000299	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BRAF—colon cancer	2.22e-05	0.000298	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—colon cancer	2.08e-05	0.000279	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.08e-05	0.000279	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—colon cancer	2.07e-05	0.000278	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—colon cancer	2.03e-05	0.000273	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KRAS—colon cancer	1.92e-05	0.000258	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PPARG—colon cancer	1.91e-05	0.000256	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—colon cancer	1.89e-05	0.000254	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—colon cancer	1.76e-05	0.000237	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—colon cancer	1.71e-05	0.000229	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRAS—colon cancer	1.63e-05	0.000219	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CTNNB1—colon cancer	1.61e-05	0.000215	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—EP300—colon cancer	1.57e-05	0.000211	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1A—colon cancer	1.57e-05	0.00021	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EP300—colon cancer	1.49e-05	0.0002	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SRC—colon cancer	1.45e-05	0.000195	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT1—colon cancer	1.44e-05	0.000193	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NRAS—colon cancer	1.4e-05	0.000187	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—colon cancer	1.3e-05	0.000175	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—colon cancer	1.3e-05	0.000174	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—colon cancer	1.27e-05	0.000171	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—EP300—colon cancer	1.25e-05	0.000168	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KRAS—colon cancer	1.2e-05	0.000161	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—colon cancer	1.16e-05	0.000156	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—colon cancer	1.1e-05	0.000148	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HRAS—colon cancer	1.02e-05	0.000137	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKT1—colon cancer	9.51e-06	0.000128	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—colon cancer	9.24e-06	0.000124	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT1—colon cancer	9.02e-06	0.000121	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKT1—colon cancer	7.55e-06	0.000101	CbGpPWpGaD
